Cardiovascular Disease
Showing NaN - NaN of 28
Tachycardia, Diabetes, Cardiovascular Disease Trial in Worldwide (Subcutaneous Implantable Cardioverter Defibrillator)
Active, not recruiting
- Tachycardia
- +2 more
- Subcutaneous Implantable Cardioverter Defibrillator
-
Huntsville, Alabama
- +48 more
Jan 26, 2023
Risk Communication Within Mexican-American Families
Completed
- Breast Cancer
- +3 more
- Family Health History
-
Houston, TexasMD Anderson Cancer Center
Jan 13, 2023
Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease Trial in Houston (Comprehensive therapy program for risk factor
Active, not recruiting
- Cardiovascular Disease
- +3 more
- Comprehensive therapy program for risk factor modification
-
Houston, TexasWeatherhead PET Center, Memorial Hermann Hospital TMC
May 20, 2022
Cardiovascular Disease, Acute Coronary Syndrome Trial in United States (Multifaceted Intervention with pharmacist and IVR)
Completed
- Cardiovascular Disease
- Acute Coronary Syndrome
- Multifaceted Intervention with pharmacist and IVR
-
Aurora, Colorado
- +14 more
Feb 8, 2022
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
Diabetes, Hyperlipidemia, Hypertension Trial in United States (CVRS Intervention)
Completed
- Diabetes
- +3 more
- CVRS Intervention
-
Gainesville, Florida
- +17 more
Jul 22, 2021
Elevated Lipoprotein(a), Cardiovascular Disease Trial in Worldwide (ISIS 681257, Placebo)
Completed
- Elevated Lipoprotein(a)
- Cardiovascular Disease
- ISIS 681257
- Placebo
-
Cottonwood, Arizona
- +31 more
Oct 26, 2020
Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)
Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)
Terminated
- Cardiovascular Disease
- Dalcetrapib
- Placebo
-
Los Angeles, California
- +109 more
Mar 20, 2020
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1595 more
Apr 18, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1745 more
Jun 14, 2018
Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)
Completed
- Cardiovascular Disease
-
Decatur, Georgia
- +202 more
Jun 12, 2018
Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab (Humira), Placebo Injection, NB-UVB phototherapy)
Completed
- Psoriasis
- Cardiovascular Disease
- Adalimumab (Humira)
- +2 more
-
Sacramento, California
- +8 more
Apr 23, 2018
Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab)
Completed
- Psoriasis
- Cardiovascular Disease
-
Sacramento, California
- +8 more
Apr 23, 2018
Cardiovascular Disease Trial in Worldwide (EVARREST™ Fibrin Sealant Patch, Topical hemostat)
Completed
- Cardiovascular Disease
- EVARREST™ Fibrin Sealant Patch
- Topical hemostat
-
Atlanta, Georgia
- +23 more
Aug 14, 2017
Cardiovascular Disease, Blood Pressure Trial in Houston (Pumpkin Seeds)
Withdrawn
- Cardiovascular Disease
- Blood Pressure
- Pumpkin Seeds
-
Houston, TexasTexas Woman's University
May 24, 2017
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Hypertriglyceridemia, Cardiovascular Disease Trial in United States (Olive oil, 4g, omega-3-carboxylic acids, 2g,
Completed
- Hypertriglyceridemia
- Cardiovascular Disease
- Olive oil, 4g
- +2 more
-
Muscle Shoals, Alabama
- +89 more
Nov 27, 2014
Physician Utilization of Shock Reduction Programming
Completed
- Cardiovascular Disease
- Therapy Programming Report (TPR)
-
Anniston, Alabama
- +103 more
Jul 1, 2014
Cardiovascular Disease, Coronary Artery Disease Trial in United States (saphenous vein graft, radial artery graft)
Completed
- Cardiovascular Disease
- Coronary Artery Disease
- saphenous vein graft
- radial artery graft
-
Birmingham, Alabama
- +10 more
Apr 18, 2014
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014